Skip to main content
. 2010 Nov;64(12):1609–1618. doi: 10.1111/j.1742-1241.2010.02520.x

Figure 3.

Figure 3

(A) Mean OGLDs prescribed. (B) Mean change in daily basal insulin dose (U/kg) over 12 months. (C) Mean weight change in 12 months prior to and after commencing insulin (unadjusted data). HbA1c, glycated haemoglobin; NPH, neutral protamine Hagedorn; OGLD, oral glucose-lowering drug. The last measurement prior to commencing insulin is at −3 months